Strawbridge RJ, Silveira A, Hoed M den, et al. Identification of a novel proinsulin-associated SNP and demonstration that proinsulin is unlikely to be a causal factor in subclinical vascular remodelling using Mendelian randomisation. Atherosclerosis. 2017;266:196-204. doi:10.1016/j.atherosclerosis.2017.09.031
Lee JM, Chao MJ, Harold D, et al. A modifier of Huntington’s disease onset at the MLH1 locus. Hum Mol Genet. 2017;26(19):3859-3867. doi:10.1093/hmg/ddx286
Ferreira MAR, O’Donovan MC, Meng YA, et al. Collaborative genome-wide association analysis supports a role for ANK3 and CACNA1C in bipolar disorder. Nat Genet. 2008;40(9):1056-8. doi:10.1038/ng.209
Long JD, Lee JM, Aylward EH, et al. Genetic Modification of Huntington Disease Acts Early in the Prediagnosis Phase. Am J Hum Genet. 2018;103(3):349-357. doi:10.1016/j.ajhg.2018.07.017
Garber M, Zody MC, Arachchi HM, et al. Closing gaps in the human genome using sequencing by synthesis. Genome Biol. 2009;10(6):R60. doi:10.1186/gb-2009-10-6-r60
Zody MC, Garber M, Sharpe T, et al. Analysis of the DNA sequence and duplication history of human chromosome 15. Nature. 2006;440(7084):671-5. doi:10.1038/nature04601
Tai DJC, Ragavendran A, Manavalan P, et al. Engineering microdeletions and microduplications by targeting segmental duplications with CRISPR. Nat Neurosci. 2016;19(3):517-22. doi:10.1038/nn.4235
Dietrich WF, Radany EH, Smith JS, Bishop JM, Hanahan D, Lander ES. Genome-wide search for loss of heterozygosity in transgenic mouse tumors reveals candidate tumor suppressor genes on chromosomes 9 and 16. Proc Natl Acad Sci U S A. 1994;91(20):9451-5.